Physician

Daniel M Nasr, M.D.

According to 2025 Medicare claims, Daniel Nasr, M.D. (NPI: 1033327309) practices pain management in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is CENTER FOR INTERVENTIONAL PAIN SPINE LLC (NPI: 1144527003; TIN: 274940541) and primary practice location at 19044-2248.

Nasr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 8,368 HCPCS/CPT codes, and received $260,814 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 3,584 prescription claims across 481 beneficiaries totaling $267,710 in drug costs, led by Oxycontin (Oxycodone Hcl). 2020 DME data shows 14 claims. Open Payments data shows 65 records totaling $1,378. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $121,259 to $260,814. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	486	1,765	$121,259
2016	524	2,064	$137,665
2017	580	1,631	$103,946
2018	484	7,743	$223,723
2019	565	13,787	$403,634
2020	379	6,405	$322,835
2021	344	7,059	$349,496
2022	334	5,990	$289,303
2023	331	6,820	$252,210
2024	349	8,368	$260,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	199	1,137	$125,423
2016	293	1,987	$305,389
2017	239	1,538	$216,576
2018	431	2,548	$221,714
2019	481	3,293	$249,555
2020	384	2,591	$236,729
2021	335	2,350	$189,823
2022	407	2,953	$226,900
2023	520	3,254	$256,421
2024	481	3,584	$267,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	16	$12,589
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	13	13	$10,139
2020	14	14	$11,031
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	111	192	$242
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	785	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	160	292	$58
96127	Assessment of emotional or behavioral problems	330	3,084	$3
96160	Administration and interpretation of patient-focused health risk assessment	314	948	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	105	3,088	$70,251
Xtampza Er	Oxycodone Myristate	79	2,355	$47,305
Belbuca	Buprenorphine Hcl	21	628	$19,058
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	658	17,625	$16,523
Oxycodone Hcl	Oxycodone Hcl	577	16,358	$12,123

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$1,378	Vertos Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel M. Nasr, M.D.?

Tedicare shows public-source Medicare data for Daniel M. Nasr, M.D. (NPI 1033327309), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel M. Nasr, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel M. Nasr, M.D.?

Daniel M. Nasr, M.D. is linked to CENTER FOR INTERVENTIONAL PAIN SPINE LLC (billing NPI 1144527003) in the available physician profile data.

Does Daniel M. Nasr, M.D. have Open Payments data?

Daniel M. Nasr, M.D. has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.